comparemela.com

Latest Breaking News On - Richard william scalzo - Page 1 : comparemela.com

Dyne Therapeutics, Inc (NASDAQ:DYN) Receives $36 20 Consensus Target Price from Brokerages

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) has been assigned a consensus recommendation of “Buy” from the seven analysts that are covering the company, Marketbeat reports. Six investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 12-month price objective among […]

Dyne Therapeutics (NASDAQ:DYN) Price Target Raised to $31 00

Dyne Therapeutics (NASDAQ:DYN – Free Report) had its price objective increased by Chardan Capital from $20.00 to $31.00 in a research report sent to investors on Friday morning, Stock Target Advisor reports. Chardan Capital currently has a buy rating on the stock. Several other equities research analysts have also recently issued reports on the stock. […]

Dyne Therapeutics (DYN) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Dyne Therapeutics (NASDAQ:DYN – Free Report) in a research report report published on Wednesday morning, Benzinga reports. They currently have a $36.00 target price on the stock. HC Wainwright also issued estimates for Dyne Therapeutics’ Q1 2024 earnings at ($0.83) EPS, Q2 2024 earnings at ($0.83) […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.